Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of CD133+ parenchymal cells in the liver: histology and culture.

World journal of gastroenterology - 21 Oct 2009

Yoshikawa Seiichi, Zen Yoh, Fujii Takahiko, Sato Yasunori, Ohta Tetsuo, Aoyagi Yutaka, Nakanuma Yasuni

Abstract excerpt

AIM: To reveal the characteristics of CD133(+) cells in the liver. METHODS: This study examined the histological characteristics of CD133(+) cells in non-neoplastic and neoplastic liver tissues by immunostaining, and also analyzed the biological characteristics of CD133(+) cells derived from human hepatocellular carcinoma (HCC) or cholangiocarcinoma cell lines. RESULTS: Immunostaining revealed constant expression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Separation
Share to AC133 Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to alpha-Fetoproteins

Share to Bile Duct Neoplasms

Share to Bile Ducts, Intrahepatic

Share to Cholangiocarcinoma

Share to Glycoproteins

Share to Keratin-19

Source

Open in PubMed Open full text

Identifiers

PMID: 19842219
DOI: 10.3748/wjg.15.4896
PMCID: PMC2764966

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of CD133+ parenchymal cells in the liver: histology and culture.PMID 19842219Read ↗

CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicitySemantic proximity Read ↗

Cancer stem/progenitor cells are highly enriched in CD133<sup>+</sup>CD44<sup>+</sup> population in hepatocellular carcinomaSemantic proximity Read ↗

CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma.Semantic proximity Read ↗

Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor CellsSemantic proximity Read ↗

Oncogenic driver genes and tumor microenvironment determine the type of liver cancerSemantic proximity Read ↗

MicroRNAs involved in neoplastic transformation of liver cancer stem cellsSemantic proximity Read ↗

Identification and characterization of tumorigenic liver cancer stem/progenitor cells.Semantic proximity Read ↗

Regulatory role of miR-142-3p on the functional hepatic cancer stem cell marker CD133Semantic proximity Read ↗

Combined hepatocellular cholangiocarcinoma: Controversies to be addressed.Semantic proximity Read ↗

CD203c is expressed by human fetal hepatoblasts and distinguishes subsets of hepatoblastomaSemantic proximity Read ↗

Characterization of a Side Population of Cancer Cells from Human Gastrointestinal SystemSemantic proximity Read ↗

Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.